M35 Peptide is primarily used in research settings for its potential neuroprotective properties. It has been investigated for its ability to modulate cellular pathways involved in neuronal survival and inflammation, making it a candidate of interest in studies related to neurodegenerative conditions such as Alzheimer's disease. The peptide is also explored for its role in promoting cognitive function and synaptic plasticity in preclinical models. Due to its stability and cell-penetrating ability, M35 is utilized in experimental assays to assess intracellular mechanisms in brain tissue. Its application remains confined to laboratory research and is not approved for clinical or therapeutic use in humans.